Endogenous cannabinoid receptor mixed agonist/antagonist found in higher concentrations peripherally than anandamide. Full agonist at GPR55 and CB 2 and partial agonist/antagonist at CB 1 (EC 50 values are 12, 381 and 2920 nM at GPR55, CB 2 and CB 1 receptors respectively). Induces hypothermia in vivo . Also available as part of the Cannabinoid Receptor Agonist Tocriset™ and Endocannabinoid Tocriset™ .